Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J W, Nalwalk"'
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 303(1)
Improgan, a nonopioid antinociceptive agent, activates descending, pain-relieving mechanisms in the brain stem, but the receptor for this compound has not been identified. Because cannabinoids also activate nonopioid analgesia by a brain stem action,
Autor:
L B, Hough, J W, Nalwalk, B Y, Li, R, Leurs, W M, Menge, H, Timmerman, M E, Carlile, C, Cioffi, M, Wentland
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 283(3)
Recent studies have shown that cimetidine, burimamide and improgan (also known as SKF92374, a cimetidine congener lacking H2 antagonist activity) induce antinociception after intracerebroventricular administration in rodents. Because these substances
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(2)
The antinociceptive and pharmacological properties of the H2 receptor antagonist cimetidine and a novel cimetidine analog, SKF92374, were characterized. On both the hot-plate and tail-flick nociceptive tests, cimetidine and SKF92374 induced complete,
Autor:
C E, Tedford, S L, Yates, G P, Pawlowski, J W, Nalwalk, L B, Hough, M A, Khan, J G, Phillips, G J, Durant, R C, Frederickson
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 275(2)
GT-2016, a non-thiourea-containing imidazole, has been developed as a histamine H3 antagonist. In vitro and in vivo studies in rats were conducted to characterize receptor selectivity and autoreceptor functionality for GT-2016. GT-2016 demonstrated h
Publikováno v:
Biochemical pharmacology. 47(2)
The actions of S-alpha-fluoromethylhistidine (FMH), an irreversible inhibitor of the histamine biosynthetic enzyme histidine decarboxylase (HD), were studied on rat brain HD, as measured by a recently developed CO2-trapping enzymatic method. As expec